Clinical Evidence Comparison: What UK Studies Reveal
Mounjaro vs Wegovy Dosage Schedules: Understanding the Clinical Protocols
When comparing Mounjaro vs Wegovy dosage regimens, both prescription-only medicines follow structured escalation protocols designed to minimise side effects whilst optimising therapeutic outcomes. Wegovy (semaglutide) progresses through five distinct doses: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. This GLP-1 receptor agonist requires consistent weekly injections using the FlexTouch pen system. Mounjaro (tirzepatide) follows a different trajectory, utilising four escalation phases over 16-20 weeks, reaching its maximum 15mg maintenance dose. The dual GIP and GLP-1 receptor agonist mechanism distinguishes Mounjaro's approach to appetite regulation and glucose control.
Storage requirements also differentiate these treatments when evaluating Mounjaro vs Wegovy dosage considerations for UK patients. Wegovy offers superior travel flexibility, maintaining stability for six weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require initial refrigeration at 2-8°C and should never be frozen. EverydayMeds ensures proper cold-chain delivery for both treatments, maintaining therapeutic integrity from our GPhC-registered pharmacy (#9012878) directly to your door. Our temperature-controlled packaging ensures medication efficacy regardless of which treatment your prescriber recommends.
UK Pricing Structure: Mounjaro vs Wegovy Dosage Costs Compared
Understanding the financial commitment for Mounjaro vs Wegovy dosage protocols helps UK patients make informed treatment decisions. Wegovy pricing at EverydayMeds reflects the dose escalation schedule: 0.25mg starter dose costs £79.99, progressing to 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and 2.4mg maintenance (£209.99) after applying discount codes at checkout. New customers benefit from code FIRST40, whilst returning patients use DOSE25 to reach these final prices. Bundle options provide supply security without multiple ordering requirements - our Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering the initial three-month escalation period.
Mounjaro pricing follows a different structure reflecting its unique dosing schedule and dual-hormone mechanism. When comparing Mounjaro vs Wegovy dosage costs, patients should consider both the escalation phase expenses and long-term maintenance requirements. EverydayMeds offers both treatments through identical clinical pathways - a comprehensive 3-minute online assessment followed by expert prescriber review. Our pricing transparency ensures no hidden fees beyond the stated medication costs, with next-day delivery included for approved prescriptions. Bundle options for Wegovy include the Ultimate Stability Trio (three 2.4mg pens for £649.99), providing three months of maintenance supply once optimal dosing is established.
STEP Trial Evidence: Wegovy's Clinical Weight Loss Results
Clinical evidence from the landmark STEP trials provides compelling data when evaluating Mounjaro vs Wegovy dosage effectiveness for weight management. STEP 1 demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo treatment. STEP 3 results showed enhanced outcomes (~16% weight reduction) when combining Wegovy with intensive behavioural therapy support, as cited in Wilding et al., NEJM, 2021.
Long-term sustainability data from STEP 5 revealed that patients maintained approximately 15.2% weight reduction at two years, whilst the SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events. These results specifically apply to the full Wegovy dosing protocol, reaching the 2.4mg maintenance dose through proper escalation phases. When comparing Mounjaro vs Wegovy dosage outcomes, both treatments show substantial efficacy in their respective clinical programmes, though direct head-to-head comparisons aren't available due to different trial designs and patient populations.
GLP-1 Mechanism: How Wegovy Supports Weight Management
Wegovy's semaglutide component functions as a GLP-1 receptor agonist, mimicking natural incretin hormones that regulate appetite and food intake. This mechanism reduces hunger signals whilst promoting feelings of fullness after smaller meals, supporting sustainable eating habit changes. The medication works on brain appetite centres, potentially reducing food cravings and emotional eating patterns that contribute to weight gain. Weekly injections maintain consistent therapeutic levels, optimising the appetite-regulating effects throughout each dosing interval. When comparing Mounjaro vs Wegovy dosage mechanisms, Wegovy's single-hormone approach provides targeted GLP-1 pathway activation, whilst Mounjaro's dual GIP/GLP-1 mechanism offers broader metabolic effects. Both approaches require combination with reduced-calorie diets and increased physical activity to achieve optimal weight management outcomes demonstrated in clinical trials.
EverydayMeds Ordering Process: From Assessment to Delivery
Accessing either treatment through EverydayMeds follows our streamlined clinical pathway designed for UK patients seeking professional weight management support. Our 3-minute online clinical assessment captures essential medical history, current medications, weight management goals, and relevant health conditions that influence prescriber decisions. Following submission, our qualified prescribers review applications within standard 3 working days, with express 24-hour review available for urgent requirements. Once approved, both Wegovy and Mounjaro ship via next-day delivery using specialist cold-chain packaging to maintain therapeutic integrity. Our GPhC-registered pharmacy service (#9012878) ensures full regulatory compliance whilst providing convenient access to these prescription-only medicines. The entire process from initial assessment to medication delivery typically completes within 4-5 days, enabling prompt treatment initiation under proper medical supervision.
Storage and Administration: Practical Considerations
Proper storage and administration techniques significantly impact treatment success when comparing Mounjaro vs Wegovy dosage regimens. Both medications require refrigeration at 2-8°C before first use, though Wegovy offers superior travel convenience with six weeks' stability at room temperature below 30°C. Weekly injection schedules should maintain consistent timing - many patients prefer Sunday evenings to minimise potential side effects during working days. The FlexTouch pen system used for Wegovy provides precise dose delivery with clear visual confirmation of injection completion. Injection site rotation between thigh, abdomen, and upper arm reduces localised skin reactions and ensures optimal absorption. Both treatments should never be shaken vigorously or frozen, as this compromises medication integrity and therapeutic effectiveness.
Trial Design Differences: Understanding Mounjaro vs Wegovy Dosage Studies
When evaluating Mounjaro vs Wegovy dosage effectiveness, understanding clinical trial methodologies helps interpret published results appropriately. STEP trials for Wegovy enrolled specific patient populations with defined BMI criteria, using particular behavioural interventions and follow-up schedules that influence reported outcomes. SURMOUNT trials for Mounjaro utilised different inclusion criteria, intervention protocols, and endpoint measurements, making direct percentage comparisons potentially misleading. Both trial programmes demonstrate substantial weight management benefits compared to placebo treatments, validating each medication's therapeutic value within its tested parameters.
UK healthcare providers consider these evidence bases alongside individual patient factors when recommending treatment options. EverydayMeds prescribers evaluate medical history, previous weight management attempts, concurrent medications, and personal preferences to guide appropriate selection between these evidence-based therapies. Both Wegovy and Mounjaro represent significant advances in prescription weight management, offering UK patients clinically-proven alternatives to traditional diet and exercise approaches when these alone prove insufficient for sustainable weight reduction.
Making Your Choice: Expert Support and Next Steps
Selecting between these advanced weight management treatments requires professional guidance tailored to individual circumstances and medical requirements. EverydayMeds provides both Wegovy and Mounjaro through identical clinical pathways, ensuring patients receive appropriate treatment regardless of prescriber recommendations. Our discount codes (FIRST40 for new customers, DOSE25 for returning patients) reduce treatment costs whilst maintaining full clinical oversight and pharmaceutical quality standards. Bundle options provide supply security during critical escalation phases, preventing treatment interruptions that could compromise therapeutic outcomes. Begin your weight management journey today through our comprehensive online assessment, supported by our qualified prescriber team and next-day delivery service across the UK.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
